5 More Aetna-CVS Deal Details, from Aetna’s SEC Filings
‘Leave Your Checkbook at Home’: New Seminar Alert Update
America’s Retirement System Is Too Inconsistent
Americo Financial Life and Annuity Insurance Company has introduced an unusual product: a single-premium long-term care insurance (LTCI) policy aimed at people who already need long-term care (LTC) services.
Americo has designed the new Reliable Living Plan policy to provide a monthly cash indemnity benefit as long as an eligible insured needs qualified LTC services.
(Related: Saving LTCI and 9 Other Top Treasury Life and Annuity Projects)
To be eligible to have the policy, and to get the benefits, policyholder must be age 65 or older. The policyholder also must already need substantial assistance with at least two “activities of daily living,” or need substantial supervision due to dementia or some other form of cognitive impairment.
The kinds of LTC services that count as “qualified LTC services” include home health care, adult day care, assisted living care and nursing home care.
Top Stocks To Invest In Right Now: Markel Corporation(MKL)
- [By Matthew Frankel]
Markel (NYSE:MKL) has been referred to as a mini-Berkshire many times, and for good reason. The company uses the same general business model as Warren Buffett does at Berkshire, using the cash from its insurance businesses to buy stocks and entire companies.
- [By Ashley Moore]
Here is a table of the 10 most expensive stocks trading on U.S. markets today:
Company (Ticker)Price per ShareMarket CapBerkshire Hathaway Inc. (NYSE: BRK-A)$ 257,227.52$ 419.50 billionSeaboard Corp. (NYSEMKT: SEB)$ 3,760.00$ 4.48 billionNVR Inc. (NYSE: NVR)$ 1,944.23$ 7.19 billionThe Priceline Group Inc. (Nasdaq: PCLN)$ 1,727.94$ 80.82 billionMarkel Corp. (NYSE: MKL)$ 978.51$ 13.78 billionWhite Mountains Insurance Group Ltd. (NYSE: WTM)$ 935.01$ 4.25 billionAmazon.com Inc. (Nasdaq: AMZN)$ 846.08$ 408.27 billionAlphabet Inc. (Nasdaq: GOOGL)$ 844.06$ 582.85 billionAutoZone Inc. (NYSE: AZO)$ 744.26$ 21.04 billionIntuitive Surgical Inc. (Nasdaq: ISRG)$ 735.63$ 28.41 billion
- [By Andy Pai]
Akre capital often holds positions for over ten years. As long as a company is able to keep increasing its economic value, the firm will hold a stock. Although the firm is a long-term investor, Akre doesn't attribute its success to ‘buy and hold' investing, but to the quality of the companies they buy. Some of the companies' long-term holdings have included Markel Corporation (NYSE: MKL), Dollar Tree, Inc. (NASDAQ: DLTR) and Enstar Group Ltd. (NASDAQ: ESGR).
Top Stocks To Invest In Right Now: NetApp Inc.(NTAP)
- [By Lisa Levin]
Analysts at Piper Jaffray upgraded NetApp Inc. (NASDAQ: NTAP) from Neutral to Overweight and raised the price target from $37.00 to $46.00.
NetApp shares rose 0.33 percent to close at $39.58 on Monday.
- [By WWW.THESTREET.COM]
NetApp (NTAP) was upgraded to buy from hold at Drexel Hamilton. $52 price target. The company continues to execute a successful business transition, Drexel said.
- [By Lisa Levin]
Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.
- [By Matt Hogan]
Apple EBITDA Margins vs Peers Chart Apple's EBITDA margins vs technology peers: Western Digital Corp. (NASDAQ: WDC), HP Inc. (NYSE: HPQ), Hewlett Packard Enterprise Co. (NYSE: HPE) and NetApp Inc. (NASDAQ: NTAP).
Top Stocks To Invest In Right Now: Ionis Pharmaceuticals, Inc.(IONS)
- [By Elizabeth Balboa]
Here is a preview of the offerings set between June 27 and June 30.
11 IPOs This Week Avenue Therapeutics, Inc. (ATXI) will issue 5 million shares between $5 and $7 Tuesday on the Nasdaq. A Fortress Biotech Inc (NASDAQ: FBIO) subsidiary, the pharmaceutical acquires, develops and commercializes products for in-hospital use, such as its post-operative palliative. Esquire Financial Holdings, Inc. (ESQ) will issue more than 2.36 shares between $14 and $16 Tuesday on the Nasdaq. The business-focused commercial bank has two locations in New York and Florida. Mersana Therapeutics, Inc. (MRSN) will issue 5 million shares between $14 and $16 Wednesday on the Nasdaq. The clinical-stage pharmaceutical specializes in immunoconjugate therapies targeting diverse forms of cancer. TPG Pace Holdings Corp. (TPGHU) will issue 40 million shares at $10 Wednesday on the New York Stock Exchange. Formed by TPG, the firm acquires relevant businesses and stocks across industries, from health care and digital media to real estate and energy. Aileron Therapeutics Inc (ALRN) will issue 3.75 million shares between $15 and $17 Thursday on the Nasdaq. The biopharmaceutical firm targets suppressor proteins to halt tumor progression. Blue Apron Holdings, Inc. (APRN) will issue 30 million shares between $15 and $17 Thursday on the NYSE. The meal-kit service delivers pre-portioned ingredients directly to the consumer. Byline Bancorp, Inc. (BY) will issue 5.7 million shares between $19 and $21 Thursday on the NYSE. The century-old commercial bank has more than 50 branches in the Chicago and Milwaukee areas with offices nationwide. Dova Pharmaceuticals, Inc.(DOVA) will issue more than 4.06 million shares between $15 and $17 Thursday on the Nasdaq. As a clinical-stage company, Dova acquires, develops and commercializes drug candidates for rare diseases. Tintri, Inc. (TNTR) will issue 8.7 million shares between $10.50 and $12.50 Thursday on the Nasdaq. With cloud management software, all-flash stor
- [By Brian Orelli]
Ionis Pharmaceuticals (NASDAQ:IONS) gave investors an update on its pipeline today with a slide deck that contained a whopping 65 entries. The whole presentation is worth a listen, but here are the five slides investors absolutely must see.
- [By Lisa Levin] Gainers
AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.
Check out these big penny stock gainers and losers
- [By Keith Speights]
Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).
- [By Cory Renauer]
Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.
- [By WWW.THESTREET.COM]
Coming up in this episode of Mad Money: Cramer interviews Dr. Stanley Crooke, CEO of Ionis Pharmaceuticals (IONS) . And, here’s Cramer’s read on Trump’s view of China. Plus, don’t miss the Lightning Round. Which stocks in Cramer bullish on?
Top Stocks To Invest In Right Now: Resolute Energy Corporation(REN )
- [By Elizabeth Balboa]
The activist hedge fund’s latest 13F revealed a stake in Resolute Energy Corp (NYSE: REN), and on Monday, it announced a new position in EQT Corporation (NYSE: EQT).
- [By Ezra Schwarzbaum]
Related Links: Magellan Midstream Riding The Wave Of Rising US Oil Exports
Resolute Energy Corp (NYSE: REN), $40 Price Target
Moving into the late-2014 downturn, Resolute had an over-levered balance sheet, flat production and a wide geographical spread.
- [By WWW.THESTREET.COM]
Or how about Resolute Energy (REN) , which has a big position in the Permian. Why is that stock not quitting? Same with Diamondback Energy (FANG) . How can that one keep roaring?
Top Stocks To Invest In Right Now: Tandem Diabetes Care, Inc.(TNDM)
- [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
- [By Lisa Levin]
Shares of Tandem Diabetes Care Inc (NASDAQ: TNDM) were down 58 percent to $2.25 after the company posted downbeat quarterly results.
Cempra Inc (NASDAQ: CEMP) was down, falling around 59 percent to $7.69 after the FDA raised liver safety issues in its review of the company's experimental drug to treat community acquired pneumonia. Baird downgraded Cempra from Outperform to Underperform.
- [By Lisa Levin]
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.
- [By Paul Ausick]
Tandem Diabetes Care Inc. (NASDAQ: TNDM) dropped nearly 26% Thursday, to post a new 52-week low of $1.15 after closing at $1.55 on Wednesday. The stock’s 52-week high is $11.30. Volume was more than 20 times the daily average of around 290,000. The company announced an underwritten secondary offering of 18 million shares at $1.25 per share.